DOJ Brings First Criminal Charges for Collusion in Labor Markets
Client Alert | 2 min read | 12.11.20
Yesterday, the Antitrust Division of the Department of Justice announced its first criminal wage-fixing prosecution, charging the former owner of a Texas home health care staffing agency with violating Section 1 of the Sherman Act by participating in a conspiracy to suppress rates for physical therapists and physical therapy assistants.
Since October 2016, when it first released guidance on “no-poach” and wage-fixing agreements, the DOJ has repeatedly emphasized its intent to bring criminal charges for collusion in the labor and employment markets, but this is the first such action.
This indictment serves as a warning to all employers, not just those in the healthcare industry, that agreements with competitors limiting salary, benefits, or other terms of employment raise enormous antitrust risks, including substantial fines for companies and jail terms for individuals responsible for the conduct. Criminal prosecution of no-poach and wage-fixing agreements is a significant priority for the DOJ, and there are many open grand jury investigations into similar HR practices across a wide range of industries.
The defendant, Neeraj Jindal, the former owner of Integrity Home Therapy, is alleged to have agreed with a competing therapy staffing agency from March to August 2017 to reduce the rates paid by each company for physical therapists and physical therapy assistants. Jindal is also alleged to have separately reached out to four other competing agencies about collectively decreasing rates.
The two-count indictment also charges Jindal with obstruction of the Federal Trade Commission’s related investigation into the same underlying conduct, by making false and misleading statements, including in Investigational Hearings, and withholding relevant information in document productions.
In 2018, the FTC resolved an investigation into alleged violations of Section 5 of the FTC Act by Jindal and Your Therapy Source with a consent agreement prohibiting the respondents from entering into any agreement to lower, maintain, or stabilize compensation for employees and contractors and prohibiting the exchange of information related to compensation. Commissioner Chopra dissented from the final consent agreement in that matter because the penalties were not severe enough in light of the “unambiguous evidence that revealed a conspiracy to fix wages.” The indictment issued this week appears to address those concerns.
The DOJ’s action also serves as an important reminder for companies to ensure that their compliance programs are current, comprehensive, and effective, and ensure that employees responsible for HR activities are appropriately trained on the antitrust risks associated with HR practices.
Contacts
Insights
Client Alert | 4 min read | 05.01.26
Federal Court Blocks Trump Administration Policies Restricting Wind and Solar Permitting
A coalition of regional clean energy trade associations — including RENEW Northeast, Alliance for Clean Energy New York, Southern Renewable Energy Association, and Interwest Energy Alliance — along with the Green Energy Consumers Alliance (GECA), filed suit in December 2025 against the Department of the Interior (DOI), the Bureau of Land Management, the Bureau of Ocean Energy Management, the U.S. Fish and Wildlife Service (USFWS), and the Army Corps of Engineers. The complaint alleged that five agency actions, issued in response to a series of executive orders and presidential memoranda beginning on January 20, 2025, violated the Administrative Procedure Act (APA) by arbitrarily halting or restricting federal permitting for wind and solar energy projects. Plaintiffs sought a preliminary injunction to halt enforcement of these policies while the litigation proceeds. See Renew Northeast, et al. v. U.S. Dep’t of Interior, et al., No. 25-cv-13961-DJC, (D. Mass. Apr. 21, 2026) ECF Dkt. 89.
Client Alert | 8 min read | 05.01.26
Pre-Approved: ICO Publishes Guidance on "Recognised Legitimate Interests”
Client Alert | 6 min read | 04.29.26
CMS Seeks to Expand Interoperability Requirements to Drug Pre-Authorization (FAQ)
Client Alert | 8 min read | 04.27.26



